Accelerating Immune Tolerance in Neurological Diseases: Neuromyelitis Optica Spectrum Disorder (NMOSD) as a Model of Progress

Time: 9:00 am
day: Conference Day One


  • Proving and following the desired impact of tolerance on the immune system
  • Moving towards harmonization of clinical trial design and implementation in NMOSD
  • Specifying biomarkers of tolerigenesis in NMOSD and neurological diseases
  • Updating outcome measures of efficacy, durability, and patient quality of life